U.S. federal trademark · Serial No. 98391186 · Reg. No. UK00004009600
Cell therapy pharmaceutical preparations; immunotherapy preparations for use in cancer treatment and treatment of autoimmune diseases; Tcell receptors in the nature of pharmaceutical preparations for use in cancer treatment and treatment of autoimmune diseases; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment and treatment of autoimmune diseases; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment and treatment of autoimmune diseases
Cell therapy medical treatment services; medical services, namely, immunotherapy services; medical services, namely, medical treatment and immunetherapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.